CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Astellas Pharma Inc. - 4503 CFD

1499.07
0.03%
Market Trading Hours* (UTC) Opens on Monday at 00:00

Mon - Fri: 00:00 - 02:30 03:30 - 06:00

  • Summary
  • Historical Data
Trading сonditions
Spread 11.26
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.011244 %
Charges from full value of position ($-2.14)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.011244%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.010978 %
Charges from full value of position ($-2.09)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.010978%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency JPY
Margin 5%
Stock exchange Japan
Commission on trade 0%

Key Stats
Prev. Close 1499.57
Open 1488.5
1-Year Change -34.93%
Day's Range 1485.61 - 1504.86
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jun 14, 2024 1499.07 14.86 1.00% 1484.21 1505.16 1472.41
Jun 13, 2024 1499.57 -51.57 -3.32% 1551.14 1551.14 1497.58
Jun 12, 2024 1563.01 3.99 0.26% 1559.02 1564.50 1541.46
Jun 11, 2024 1572.98 -9.18 -0.58% 1582.16 1591.43 1567.89
Jun 10, 2024 1570.49 -18.95 -1.19% 1589.44 1591.04 1560.41
Jun 7, 2024 1582.45 4.78 0.30% 1577.67 1595.52 1574.27
Jun 6, 2024 1584.95 -3.99 -0.25% 1588.94 1596.82 1578.87
Jun 5, 2024 1591.44 28.33 1.81% 1563.11 1595.22 1557.91
Jun 4, 2024 1573.38 26.53 1.72% 1546.85 1574.78 1535.47
Jun 3, 2024 1551.44 -3.09 -0.20% 1554.53 1564.00 1538.47
May 31, 2024 1540.46 12.86 0.84% 1527.60 1549.54 1524.00
May 30, 2024 1512.64 -7.48 -0.49% 1520.12 1523.31 1494.08
May 29, 2024 1528.20 -23.94 -1.54% 1552.14 1552.24 1519.02
May 28, 2024 1555.93 -3.09 -0.20% 1559.02 1565.40 1544.45
May 27, 2024 1561.41 -1.10 -0.07% 1562.51 1579.87 1548.94
May 24, 2024 1560.41 16.35 1.06% 1544.06 1567.20 1535.97
May 23, 2024 1560.22 36.11 2.37% 1524.11 1566.40 1521.61
May 22, 2024 1519.62 15.46 1.03% 1504.16 1528.60 1498.66
May 21, 2024 1499.08 -0.19 -0.01% 1499.27 1504.16 1490.09
May 20, 2024 1509.05 19.25 1.29% 1489.80 1524.71 1484.60

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Astellas Pharma Inc. Company profile

About Astellas Pharma Inc

Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.

Financial summary

BRIEF: For the nine months ended 31 December 2021, Astellas Pharma Inc revenues increased 5% to Y992.29B. Net income applicable to common stockholders decreased less than 1% to Y132.49B. Revenues reflect Sales of Pharmaceuticals segment increase of 6% to Y971.11B, Other Business segment increase of 33% to Y14.07B, Americas segment increase of 15% to Y407.94B, Estabridge segment increase of 10% to Y239.22B.

Equity composition

04/2005, Company merged with Fujisawa Pharmaceutical Co., Ltd. & Name Changed from Yamanouchi Pharmaceutical Co., Ltd. FY'08 1Q&Q3 WAS & DWAS estimated and WAS used as O/S. FY'09 Q3,12 Q2 DWAS estimated.

Industry: Pharmaceuticals (NEC)

日本橋本町2-5-1
CHUO-KU
TOKYO-TO 103-8411
JP

News

Bank of Japan Preview: Markets look for guidance from BOJ about timing of next hike

The Bank of Japan meets on Friday, 14th of June, 2024. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

11:05, 12 June 2024

FOMC preview: Still expecting three rate cuts in 2024?

The Federal Reserve is expected to keep its policy unchanged on Wednesday – data from Reuters shows a 99% chance of no change. Last week’s 25-basis-point rate cut from the ECB has done nothing to change market expectations, and why should it?

08:20, 11 June 2024

US Non-Farm Payrolls Preview: Forecasts point to a stable labour market

US labour market conditions are expected to have remained stable in May. The latest Non-Farm Payrolls data will be released on Friday, June 7th, 2024, and will provide a health check on the US jobs market.

10:09, 5 June 2024

AUD/USD analysis: Focus turns to GDP data after unexpected CPI rise

Higher-than-expected monthly CPI data watered down expectations for RBA interest rate cuts in 2024; the markets will now shift attention to quarterly GDP data on Wednesday, June 5.

15:57, 4 June 2024

ECB preview: A cut, but how many more?

After months of waiting, a rate cut from the ECB on Thursday looks like a done deal. Data from Reuters shows markets pricing in a 96% chance of a 25-basis point cut from the European Central Bank following Thursday’s policy meeting.

08:54, 4 June 2024

PCE Index Preview: Forecasts point to no change in headline or core inflation from a month earlier

The markets continue to look for signals of disinflation in the United States. The latest PCE Index data, the US Federal Reserve’s preferred inflation gauge, is released on May 31, 2024.

12:44, 29 May 2024

Gold and Silver recover from last week’s pullback but face resistance ahead of US PCE

Gold and Silver move higher after last week’s pullbacks but the precious metals are struggling with resistance ahead of the US PCE release.

15:46, 28 May 2024

People also watch

Gold

2,333.42 Price
+1.270% 1D Chg, %
Long position overnight fee -0.0190%
Short position overnight fee 0.0107%
Overnight fee time 21:00 (UTC)
Spread 0.80

US100

19,677.60 Price
+0.500% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 7.0

BTC/USD

66,230.45 Price
+0.680% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

XRP/USD

0.48 Price
+2.070% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

Still looking for a broker you can trust?

Join the 620,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading